Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Reexamination Certificate
2006-08-11
2010-12-28
Shiao, Rei-tsang (Department: 1628)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
C562S512000
Reexamination Certificate
active
07858661
ABSTRACT:
A refolding agent and refolding method which make it possible to produce high-purity proteins in high productivity. The refolding agent includes a phosphorus-containing compound (A) and an oxycarbonyl group-containing compound (B). The refolding method includes the step of treating the unfolded protein with the refolding agent. As the compound (A), there may be mentioned at least one species selected from inorganic phosphoric acids, alkyl phosphate esters, sugar phosphate esters, and salts of these, and as the compound (B), there may be mentioned at least one species selected from formic acid, acetic acid, propionic acid, lactic acid, tartaric acid, and salts of these.
REFERENCES:
patent: 2004-512343 (2004-04-01), None
patent: 2004-528266 (2004-09-01), None
patent: 2004-535366 (2004-11-01), None
patent: WO 01/76638 (2001-10-01), None
patent: WO 02/34791 (2002-05-01), None
patent: WO 02/059146 (2002-08-01), None
Corday et al., 1964, CAS: 61:87131.
(2) Darensburg et al., 1995, CAS: 122:314219.
Chen et al. , 2004, CAS: 141:379203.
Crandall et al., 1999, CAS: 131:175090.
He et al., 2003, CAS: 140:25051.
Kuboi et al, “Oxidative Refolding of Lysozyme Assisted by Negatively Charged Liposomes: Relationship With Lysozyme-Medicated Fusion of Liposomes” Journal of Bioscience and Bioengineering, vol. 90, p. 14-19 (2000).
Bogdanov et al, “Phospholipid-assisted Refolding of an Integral Membrane Protein” The Journal of Biological Chemistry, vol. 274, p. 12339-12345 (1999).
Kirsch et al, “Cloning, High-Yield Expression inEscherichia Coli, and Purification of Biologically Active HIV-1 Tat Protein” Protein Expression and Purification, vol. 8, p. 75-84 (1996).
Nath et al, “α-Crystallin and ATP Facilitate the In Vitro Renaturation of Xylanase: Enhancement of Refolding by Metal Ions” Protein Science, vol. 11, p. 2727-2734 (2002).
Seibutsu Kogaku Kaisha, Feb. 25, 2005, vol. 83, pp. 90.
Daisuke Nohara et al., “Media Selection for Refolding of Thermolysin by Use of Immobilized Preparation”, Journal Bioscence & Bioengineering (2000), vol. 89, No. 2, pp. 188-192.
Irene Griswold-Prenner et al., Biochemistry, “G-Protein Effector Coupling . . . ”, (1989), vol. 28, pp. 6145-6150.
Daisuke Nohara et al., “Media Selection for Refolding of Thermolysin by Use of Immobilized Preparation”, Journal Bioscence & Bioengineering (2000), vol. 89, No. 2, pp. 188-192.
Irene Griswold-Prenner et al., Biochemistry, “G-Protein Effector Coupling . . . ”, (1989), vol. 28, pp. 6145-6150.
Kagaku Dai-jiten, vol. 2, Compact Edition 19, p. 704 (partial translation) (Sep. 10, 1976).
Kagaku Dai-jiten, vol. 3, Compact Edition 19, p. 26 (partial translation) (Sep. 10, 1976).
Kagaku Dai-jiten, vol. 3, Compact Edition 19, p. 823 (partial translation) (Sep. 10, 1976).
Kagaku Dai-jiten, vol. 8, Compact Edition 19, p. 116 (partial translation) (Sep. 10, 1976).
Kagaku Dai-jiten, vol. 3, Compact Edition 19, p. 673 (partial translation) (Sep. 10, 1976).
Miura Shuji
Yamaguchi Shunichiro
Dennison, Schultz & MacDonald
Sanyo Chemical Industries Ltd.
Shiao Rei-tsang
LandOfFree
Protein refolding agent and refolding method does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Protein refolding agent and refolding method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Protein refolding agent and refolding method will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4233683